Organization Profile

Cipher Pharmaceuticals Inc.

Cipher (TSX:CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval...

You just read:

Cipher Pharmaceuticals announces U.S. commercial entry through acquisition of INNOCUTIS

News provided by

Cipher Pharmaceuticals Inc.

Apr 13, 2015, 08:50 ET